Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

7.4K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.4K
Biostatistics: Overview01:20

Biostatistics: Overview

945
Biostatistics plays a crucial role in understanding and analyzing data in healthcare and biology. Biostatisticians conduct experiments, gather evidence, and draw meaningful conclusions using statistical methods and techniques. Different variables form the foundation of biostatistical analysis, allowing researchers to understand and interpret data effectively. These variables are classified into different types, each serving a specific purpose in statistical analysis.
Discrete variables are...
945
One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation01:24

One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation

1.3K
This lesson introduces two critical methods in pharmacokinetics, the Wagner-Nelson and Loo-Riegelman methods, used for estimating the absorption rate constant (ka) for drugs administered via non-intravenous routes. The Wagner-Nelson method relates ka to the plasma concentration derived from the slope of a semilog percent unabsorbed time plot. However, it is limited to drugs with one-compartment kinetics and can be impacted by factors like gastrointestinal motility or enzymatic degradation.
On...
1.3K
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

299
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
299
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

379
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
379
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

602
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
602

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Label-Free Malignancy Phenotyping of Living Cancer Cells by High-Performance Surface-Enhanced Raman Spectroscopy Substrates.

Micromachines·2026
Same author

Joint semiparametric kernel network regression.

Statistics in medicine·2023
Same author

Nonparametric Bayesian functional selection in 1-M matched case-crossover studies.

Statistical methods in medical research·2022
Same author

Bayesian multiple Gaussian graphical models for multilevel variables from unknown classes.

Statistical methods in medical research·2022
Same author

Proteomic analysis of alcohol-associated hepatitis reveals glycoprotein NMB (GPNMB) as a novel hepatic and serum biomarker.

Alcohol (Fayetteville, N.Y.)·2021
Same author

Flexible derivative time-varying model in matched case-crossover studies for a small number of geographical locations among the participants.

Statistical methods in medical research·2020
Same journal

A Mixture of Distributed Lag Non-Linear Models to Account for Spatially Heterogeneous Exposure-Lag-Response Associations.

Statistics in medicine·2026
Same journal

Practical Considerations for Gaussian Process Modeling for Causal Inference in Quasi-Experimental Studies With Panel Data.

Statistics in medicine·2026
Same journal

Covariate Adjustment for Wilcoxon Two Sample Statistic and Test.

Statistics in medicine·2026
Same journal

Beyond Fixed Thresholds: Optimizing Summaries of Wearable Device Data via Piecewise Linearization of Quantile Functions.

Statistics in medicine·2026
Same journal

A Causal Framework for Evaluating the Total Effect of Strategies Aiming to Expand Screening and to Improve Outcomes.

Statistics in medicine·2026
Same journal

Causal Effects on Nonterminal Event Time With Application to Antibiotic Usage and Future Resistance.

Statistics in medicine·2026
查看所有相关文章

相关实验视频

Updated: Mar 1, 2026

A Pathway Association Study Tool for GWAS Analyses of Metabolic Pathway Information
05:01

A Pathway Association Study Tool for GWAS Analyses of Metabolic Pathway Information

Published on: July 1, 2020

3.8K

灵活的贝叶斯推理用于识别显著相关的多个路径集.

PhilGeun Jin1, Youngho Yun1, Inyoung Kim1

  • 1Department of Statistics, Virginia Polytechnic Institute and State University, VA, USA.

Statistics in medicine
|February 27, 2026
PubMed
概括
此摘要是机器生成的。

这项研究引入了一种灵活的贝叶斯方法,以找到与健康结果相关的重要基因通路. 它解决了途径之间的复杂相互作用,以便在II型糖尿病等疾病中更准确地进行遗传途径分析.

关键词:
贝叶斯因子是一个贝叶斯因子.化模型的融合模型.核心机器回归的回归方法多次测试多次测试多次测试

更多相关视频

Sample Preparation and Analysis of RNASeq-based Gene Expression Data from Zebrafish
11:42

Sample Preparation and Analysis of RNASeq-based Gene Expression Data from Zebrafish

Published on: October 27, 2017

11.6K
Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization
03:08

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization

Published on: October 3, 2025

1.0K

相关实验视频

Last Updated: Mar 1, 2026

A Pathway Association Study Tool for GWAS Analyses of Metabolic Pathway Information
05:01

A Pathway Association Study Tool for GWAS Analyses of Metabolic Pathway Information

Published on: July 1, 2020

3.8K
Sample Preparation and Analysis of RNASeq-based Gene Expression Data from Zebrafish
11:42

Sample Preparation and Analysis of RNASeq-based Gene Expression Data from Zebrafish

Published on: October 27, 2017

11.6K
Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization
03:08

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization

Published on: October 3, 2025

1.0K

科学领域:

  • 遗传学 遗传学 是一个
  • 生物统计学 生物统计学
  • 计算生物学 计算生物学

背景情况:

  • 在遗传学中,基于路径的分析对于检测微妙的表达变化至关重要.
  • 生物途径之间的相互作用使边际分析复杂化,导致潜在的错误.
  • 现有的方法往往无法解释临床结果研究中的相互途径依赖性.

研究的目的:

  • 开发一种灵活的贝叶斯推理方法,用于识别具有响应变量的显著相关的高维函数 (路径).
  • 为了应对由于相互路径依赖导致的未知和复杂关系的挑战.
  • 通过计算路径相互作用来提高遗传路径分析的准确性.

主要方法:

  • 提出了一种通用的融合内核机器回归方法.
  • 开发了一个数据驱动的,灵活的贝叶斯推理框架.
  • 利用贝叶斯因子进行多次测试调整,通过灵活的结构来适应依赖性.

主要成果:

  • 拟议的方法有效地识别了与连续或二进制响应变量显著相关的高维函数.
  • 贝叶斯推理与贝叶斯因子调整成功地适应了相互路径依赖.
  • 通过模拟研究和对II型糖尿病遗传途径数据的分析证明了益处.

结论:

  • 灵活的贝叶斯推理方法为分析复杂生物系统中的高维函数提供了强大的方法.
  • 考虑途径相互作用对于准确识别重要功能和可靠的临床结果预测至关重要.
  • 该方法为基因路径分析提供了宝贵的工具,特别是在复杂的疾病,如II型糖尿病.